Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | -0.89% | 89.60 | 0.8% | $459.34m | |
| MDT | Medtronic Plc | -0.02% | 119.24 | 0.6% | $441.12m | |
| ISRG | Intuitive Surgical, Inc. | -3.68% | 567.50 | 2.4% | $435.45m | |
| DHR | Danaher Corp. | -0.69% | 161.13 | 0.7% | $347.81m | |
| BSX | Boston Scientific Corp. | -1.33% | 42.64 | 1.1% | $317.59m | |
| BDX | Becton, Dickinson & Co. | 0.48% | 279.59 | 1.1% | $315.67m | |
| TMO | Thermo Fisher Scientific, Inc. | -0.82% | 330.94 | 1.0% | $314.67m | |
| SYK | Stryker Corp. | 0.25% | 214.76 | 1.3% | $287.57m | |
| EW | Edwards Lifesciences Corp. | -0.64% | 228.97 | 1.2% | $275.29m | |
| BAX | Baxter International, Inc. | -0.24% | 90.56 | 1.8% | $248.31m | |
| ALGN | Align Technology, Inc. | -3.36% | 260.91 | 6.4% | $211.90m | |
| ABMD | ABIOMED, Inc. | -0.84% | 181.45 | 3.3% | $198.79m | |
| DXCM | DexCom, Inc. | 0.65% | 235.45 | 8.3% | $179.67m | |
| IDXX | IDEXX Laboratories, Inc. | -1.23% | 277.31 | 3.7% | $130.06m | |
| ZBH | Zimmer Biomet Holdings, Inc. | 0.19% | 148.08 | 1.7% | $116.86m |
Company Profile
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.